Gender-based differences in outpatient care of peripheral artery diseases in Germany. (14th October 2021)

• Record Type: Journal Article
• Authors: Messiha, D; Petrikhovich, O; Lortz, J; Mahabadi, A A; Hering, R; Schulz, M; Rassaf, T; Rammos, C
• Is Part Of: European heart journal. Volume 42(2021)Supplement 1
• Publication Date: 2021-10-14
• Subjects: Epidemiology, Prognosis, Outcome; Cardiology -- Periodicals; Heart -- Diseases -- Periodicals; 616.12005
• DOI: 10.1093/eurheartj/ehab724.2019
• Languages: English
• ISSNs: 0195-668X

Abstract

Abstract: Background: Peripheral artery disease (PAD) is a major manifestation of atherosclerosis and a risk factor for morbidity and mortality. Guideline-recommended therapy and specialized outpatient care are essential for optimal treatment. Gender-based inequalities in diagnosis and treatment of cardiovascular diseases are still present, despite clear guideline recommendations. Knowledge of the treatment structures in the outpatient setting are essential to identify and solve gender-based inequalities in this high-risk population. Purpose: Aim of the study was to identify gender-based inequalities in an outpatient clinic setting in terms of treatment structures and pharmacotherapy in patients with PAD. Methods: We analyzed gender-based differences in pharmacotherapy (statins, antiplatelets) and treatment by specialized outpatient care (angiology, vascular surgery, internal medicine, cardiology) in 17.633.970 patients with PAD and statutorily insurance presenting to outpatient care facilities in Germany between 2009 and 2018. The study is based on the ambulatory claims data of the panel doctors' services according to § 295 SGB V and drug prescription data according to § 300 SGB V. Diagnosis of PAD was defined upon medical diagnoses of PAD ICD I70.2–9. Statistical analysis was performed with chi-squared test for trend and two-way Anova. Results: Overall, 17.633.970 patients were included in the study and 53% were female. Only a minority of 37, 1% presented to a vascular specialist (8, 5% angiology, 10, 2% vascular surgery, 24, 6% cardiology) with no significant change over the course between 2009 and 2018. Interestingly, female patients were less likely to present to a vascular specialist and less likely to receive guideline recommended medical therapy. The gender gap between male and female patients presenting to a vascular specialist, however, narrowed in the observed time frame (angiology in 2009 1, 8% vs 2018 1, 0%, p<0, 0001; vascular surgery 2009 3, 2% vs 2018 1, 5%, p<0, 0001). Pharmacotherapy also significantly differed between female and male patients over the course of time. While prescription rates of statins and antiplatelet drugs increased in the observed time period (statins 42, 8% vs 55, 7% (male), 35, 1% vs 45% (female); antiplatelets 29, 2% vs 34, 4% (male), 20, 2 vs 24, 3% (female)), the gender gap also increased between 2009 and 2018 (7, 7% vs 10, 7%, p<0, 0001 (statins); 8, 9% vs 10%, p<0, 0001 (antiplatelets)). Conclusion: Our results demonstrate that gender-based differences in pharmacotherapy and specialized outpatient care of patients with PAD are still evident in Germany. While overall outpatient treatment by a vascular specialist and guideline recommended medical therapy of PAD with antiplatelets and statins are overall remarkably low, female patients are even less likely to receive both, compared to male patients. While adherence to guideline recommended therapy is increasing, the gender-gap still continues to widen over the course of time. Funding Acknowledgement: Type of funding sources: None.